Citi reiterates a 'Buy' rating on Medco Health (NYSE: MHS), raises price target from $55 to $57.

Citi analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE